Project Grant R01DK135511
Award Date
9/15/24
Completion Date
7/31/29
Dollars Obligated
$602K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This Project Grant award, totaling $216,736.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project aims to identify the mechanisms by which the host circadian clock and gut microbiome regulate mucus production in the large intestine to protect against infectious and chemical colitis. Key objectives include determining the specific microbiota...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) provides $1,066,994 to Rutgers, The State University to conduct research on the role of the TET3 enzyme in regulating intestinal epithelial cell homeostasis and protection against inflammatory conditions. The research aims to decipher the epigenetic and transcriptional mechanisms by which TET3-mediated DNA oxidation regulates gene expression to maintain intestinal epithelial...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is providing $220,930.00 to The Medical University of South Carolina to conduct research on elucidating the role of myosin 5B in microvilli assembly and in the setting of inflammation, with a focus on Crohn's disease. The research aims to investigate how myosin 5B regulates microvilli...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $497,370 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Regents of the University of Michigan. The grant, titled "CD45 MEDIATED REGULATION OF PMN FUNCTION DURING INTESTINAL INFLAMMATION", will fund research to determine the effects of neutrophil-specific loss of the CD45 tyrosine phosphatase on intestinal inflammation and repair processes. The...
This Project Grant award of $467,200.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research at Baylor College of Medicine to conduct high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD). The research aims to 1) screen and characterize IBD risk genes in a C. elegans microbiome model, and 2) validate IBD risk alleles in human intestinal...
This $830,500 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research by Georgetown University to investigate the role of glycosphingolipids in kidney disease associated with diabetes and obesity. The research aims to determine if inhibiting glucosylceramide synthesis can prevent kidney disease progression, improve mitochondrial function, and reduce...
This federal Project Grant award of $151,643, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on developing and evaluating Proteolysis Targeting Chimeras (PROTACs) to stabilize hypoxia-inducible factors (HIFs) as a potential therapeutic approach for inflammatory bowel disease (IBD). The principal investigator, Dr. Ornelas Sanchez, and his...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $516,648 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially derived metabolites regulate host gut inflammation. The award period runs from August 28, 2024 to February 28, 2027. The research aims to determine the regulatory...
This $1,060,675.00 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research at the University of Arizona focused on understanding how the pattern recognition receptor Absent in Melanoma 2 (AIM2) impacts intestinal stem cell differentiation and immune responses during inflammation. The project will utilize tissue-specific animal models, intestinal epithelial organoid...
This Project Grant award, valued at $643,700.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research by Cornell University to investigate the morphogenetic mechanisms governing the formation and function of the intestinal lymphatic smooth muscle-lacteal complex, which plays a critical role in dietary fat absorption and metabolism....